Guidelines for the definitions of time-to-event endpoints in randomized clinical trials: Results of the DATECAN Project for Sarcomas and GISTs von Bellera, Carine A., Ouali, Monia, Penel, Nicolas, Bonvalot, Sylvie, Casali, Paolo Giovanni, Delannes, Martine, Nielsen, Ole Steen, Mathoulin-Pelissier, Simone

Volltext

Guidelines for the definitions of time-to-event endpoints in randomized clinical trials: Results of the DATECAN Project for Breast Group von Gourgou, Sophie, Dabakuyo, Tienhan Sandrine, Asselain, Bernard, Azria, David, Cameron, David A., Cardoso, Fatima, Poortmans, Philip M.

Volltext

Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project von Kramar, A., Negrier, S., Sylvester, R., Joniau, S., Mulders, P., Powles, T., Bex, A., Bonnetain, F., Bossi, A., Bracarda, S., Bukowski, R., Catto, J., Choueiri, T.K., Crabb, S., Eisen, T., El Demery, M., Fitzpatrick, J., Flamand, V., Goebell, P.J., Gravis, G., Houédé, N., Jacqmin, D., Kaplan, R., Malavaud, B., Massard, C., Melichar, B., Mourey, L., Nathan, P., Pasquier, D., Porta, C., Pouessel, D., Quinn, D., Ravaud, A., Rolland, F., Schmidinger, M., Tombal, B., Tosi, D., Vauleon, E., Volpe, A., Wolter, P., Escudier, B., Filleron, T., Kramar, Andrew, Sylvester, Richard, Filleron, Thomas, Negrier, Sylvie, Joniau, Steven, Mulders, Peter, Powles, Thomas, Escudier, Bernard, Bex, Axel, Bonnetain, Franck, Bossi, Alberto, Braccarda, Sergio, Bukowski, Ronald, Catto, James, Choueiri, Toni, Crabb, Simon, Eisen, Tim, El Demery, Mounira, Fitzpatrick, John, Flamand, Vincent, Goebell, Peter J., Gravis, Gwendael, Houédé, Nadine, Jacqmin, Didier, Kaplan, Richard, Malavaud, Bernard, Massard, Christophe, Melichar, Bohuslav, Mourey, Loïc, Nathan, Paul, Pasquier, David, Porta, Camillo, Pouessel, Damien, Quinn, David, Ravaud, Alain, Rolland, Frédéric, Schmidinger, Manuela, Tombal, Bertrand, Tosi, Diego, Vauleon, Elodie, Volpe, Alessandro, Wolter, Pascal

Volltext

Abstract P4-17-02: Guidelines for the definitions of time-to-event endpoints in randomized clinical trials: Results of the datecan project for breast group von Gourgou-Bourgade, S, Dabakuyo-Yonli, S, Cameron, D, Cardoso, F, Poortmans, P, Asselain, B, Azria, D

Volltext

O-0001 International Experts' Consensus for the Definition of Time to Event Endpoints in Clinical Trials (DATECAN Project): Results for Pancreatic Cancer von Bonnetain, Franck, Dousseau, Adelaide, Bert, Bonsing, Bengt, Glimelius, Haustermans, Karin, Conroy, Thierry, Van Laethem, Jean Luc, Labianca, Roberto, Macarulla, Teresa, Tabernero, Josep, Lutz, Manfred, Neoptolemos, John P., De Gramont, Aimery, Group, Datecan, Collette, Laurence

Volltext